Literature DB >> 25326241

Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors.

Jonathan H Shannahan1, Ramakrishna Podila2, Abdullah A Aldossari1, Hilary Emerson1, Brian A Powell1, Pu Chun Ke1, Apparao M Rao2, Jared M Brown3.   

Abstract

Addition of a protein corona (PC) or protein adsorption layer on the surface of nanomaterials following their introduction into physiological environments may modify their activity, bio-distribution, cellular uptake, clearance, and toxicity. We hypothesize that silver nanoparticles (AgNPs) will associate with proteins common to human serum and cell culture media forming a PC that will impact cell activation and cytotoxicity. Furthermore, the role of scavenger receptor BI (SR-BI) in mediating this toxicity was evaluated. Citrate-suspended 20 nm AgNPs were incubated with human serum albumin (HSA), bovine serum albumin (BSA), high-density lipoprotein (HDL), or water (control) to form a PC. AgNPs associated with each protein (HSA, BSA, and HDL) forming PCs as assessed by electron microscopy, hyperspectral analysis, ζ-potential, and hydrodynamic size. Addition of the PC decreased uptake of AgNPs by rat lung epithelial and rat aortic endothelial cells. Hyperspectral analysis demonstrated a loss of the AgNP PC following internalization. Cells demonstrated concentration-dependent cytotoxicity following exposure to AgNPs with or without PCs (0, 6.25, 12.5, 25 or 50 μg/ml). All PC-coated AgNPs were found to activate cells by inducing IL-6 mRNA expression. A small molecule SR-BI inhibitor was utilized to determine the role of SR-BI in the observed effects. Pretreatment with the SR-BI inhibitor decreased internalization of AgNPs with or without PCs, and reduced both cytotoxicity and IL-6 mRNA expression. This study characterizes the formation of a PC on AgNPs and demonstrates its influence on cytotoxicity and cell activation through a cell surface receptor.
© The Author 2014. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  darkfield microscopy; endothelial cells; epithelial cells; hyperspectral microscopy; in vitro toxicity; nanotoxicology

Mesh:

Substances:

Year:  2014        PMID: 25326241      PMCID: PMC4274384          DOI: 10.1093/toxsci/kfu217

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  43 in total

Review 1.  Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots.

Authors:  Jim E Riviere
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2009 Jan-Feb

2.  The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles.

Authors:  M Safi; J Courtois; M Seigneuret; H Conjeaud; J-F Berret
Journal:  Biomaterials       Date:  2011-09-10       Impact factor: 12.479

3.  Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549.

Authors:  Rasmus Foldbjerg; Duy Anh Dang; Herman Autrup
Journal:  Arch Toxicol       Date:  2010-04-29       Impact factor: 5.153

4.  A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism.

Authors:  A Rigotti; B L Trigatti; M Penman; H Rayburn; J Herz; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

5.  Quantitative mechanics of endothelial phagocytosis of silicon microparticles.

Authors:  Rita E Serda; Jianhua Gu; Jared K Burks; Kim Ferrari; Chiara Ferrari; Mauro Ferrari
Journal:  Cytometry A       Date:  2009-09       Impact factor: 4.355

6.  Chemical transformations of nanosilver in biological environments.

Authors:  Jingyu Liu; Zhongying Wang; Frances D Liu; Agnes B Kane; Robert H Hurt
Journal:  ACS Nano       Date:  2012-10-17       Impact factor: 15.881

7.  Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations?

Authors:  Nancy A Monteiro-Riviere; Meghan E Samberg; Steven J Oldenburg; Jim E Riviere
Journal:  Toxicol Lett       Date:  2013-05-06       Impact factor: 4.372

8.  Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1.

Authors:  Tatyana G Vishnyakova; Alexander V Bocharov; Irina N Baranova; Zhigang Chen; Alan T Remaley; Gyorgy Csako; Thomas L Eggerman; Amy P Patterson
Journal:  J Biol Chem       Date:  2003-03-21       Impact factor: 5.157

9.  Silver nanoparticle-induced cytotoxicity in rat brain endothelial cell culture.

Authors:  Susann Grosse; Lars Evje; Tore Syversen
Journal:  Toxicol In Vitro       Date:  2012-08-29       Impact factor: 3.500

10.  Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines.

Authors:  Sophie Lanone; Françoise Rogerieux; Jorina Geys; Aurélie Dupont; Emmanuelle Maillot-Marechal; Jorge Boczkowski; Ghislaine Lacroix; Peter Hoet
Journal:  Part Fibre Toxicol       Date:  2009-04-30       Impact factor: 9.400

View more
  45 in total

Review 1.  Xenobiotic pulmonary exposure and systemic cardiovascular response via neurological links.

Authors:  Phoebe A Stapleton; Alaeddin B Abukabda; Steven L Hardy; Timothy R Nurkiewicz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

2.  Experimental challenges regarding the in vitro investigation of the nanoparticle-biocorona in disease states.

Authors:  Sherleen Xue-Fu Adamson; Zhoumeng Lin; Ran Chen; Lisa Kobos; Jonathan Shannahan
Journal:  Toxicol In Vitro       Date:  2018-05-05       Impact factor: 3.500

3.  Comparison of 20 nm silver nanoparticles synthesized with and without a gold core: Structure, dissolution in cell culture media, and biological impact on macrophages.

Authors:  Prabhakaran Munusamy; Chongmin Wang; Mark H Engelhard; Donald R Baer; Jordan N Smith; Chongxuan Liu; Vamsi Kodali; Brian D Thrall; Shu Chen; Alexandra E Porter; Mary P Ryan
Journal:  Biointerphases       Date:  2015-09-15       Impact factor: 2.456

4.  Implications of scavenger receptors in the safe development of nanotherapeutics.

Authors:  Jonathan H Shannahan; Wei Bai; Jared M Brown
Journal:  Receptors Clin Investig       Date:  2015

5.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

6.  Altered formation of the iron oxide nanoparticle-biocorona due to individual variability and exercise.

Authors:  Lisa M Kobos; Sherleen Xue-Fu Adamson; Sheelagh Evans; Timothy P Gavin; Jonathan H Shannahan
Journal:  Environ Toxicol Pharmacol       Date:  2018-07-29       Impact factor: 4.860

7.  Autophagy and autophagy dysfunction contribute to apoptosis in HepG2 cells exposed to nanosilica.

Authors:  Yongbo Yu; Junchao Duan; Yang Yu; Yang Li; Yang Zou; Yumei Yang; Lizhen Jiang; Qiuling Li; Zhiwei Sun
Journal:  Toxicol Res (Camb)       Date:  2016-03-08       Impact factor: 3.524

8.  Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.

Authors:  Suchitra Prasad; Tobias Neef; Dan Xu; Joseph R Podojil; Daniel R Getts; Lonnie D Shea; Stephen D Miller
Journal:  J Autoimmun       Date:  2017-12-16       Impact factor: 7.094

9.  Influence of carbon nanomaterial defects on the formation of protein corona.

Authors:  Bishwambhar Sengupta; Wren E Gregory; Jingyi Zhu; Siva Dasetty; Mehmet Karakaya; Jared M Brown; Apparao M Rao; John K Barrows; Sapna Sarupria; Ramakrishna Podila
Journal:  RSC Adv       Date:  2015-09-23       Impact factor: 3.361

Review 10.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery.

Authors:  Claudia Corbo; Roberto Molinaro; Alessandro Parodi; Naama E Toledano Furman; Francesco Salvatore; Ennio Tasciotti
Journal:  Nanomedicine (Lond)       Date:  2015-12-11       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.